Sumitomo To Reprioritize Pipeline After Ulotaront’s Phase III Fail
Otsuka Obtains Global Rights To Two Drugs
Sumitomo has decided to prioritize other R&D candidates over the four in its Otsuka alliance amid financial challenges • Source: Shutterstock 
